Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II study of vorozole (R83842) a new aromatase inhibitor in postmenopausal women with advanced breast cancer

Phase II study of vorozole (R83842) a new aromatase inhibitor in postmenopausal women with advanced breast cancer. Breast Cancer Res Treat. 1994; 32(Suppl 67):A154.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.